Trials of Biomarker-Guided Antimicrobial Therapy in Sepsis: Improvements in Trial Design Require Better Control Groups

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

Access to Document

@article{05b8e0352b874762ac132aca9edc3299,

title = "Trials of Biomarker-Guided Antimicrobial Therapy in Sepsis: Improvements in Trial Design Require Better Control Groups",

keywords = "C-REACTIVE PROTEIN, DURATION, PROCALCITONIN, PNEUMONIA",

author = "JIF Salluh and Pedro P{\'o}voa",

note = "PMID:24434473 WOS:000329863400014",

year = "2014",

month = feb,

doi = "10.1097/CCM.0000000000000013",

language = "English",

volume = "42",

pages = "172--172",

journal = "Critical Care Medicine",

issn = "0090-3493",

publisher = "Williams & Wilkins",

number = "2",

}

TY - JOUR

T1 - Trials of Biomarker-Guided Antimicrobial Therapy in Sepsis: Improvements in Trial Design Require Better Control Groups

AU - Salluh, JIF

AU - Póvoa, Pedro

N1 - PMID:24434473 WOS:000329863400014

PY - 2014/2

Y1 - 2014/2

KW - C-REACTIVE PROTEIN

KW - DURATION

KW - PROCALCITONIN

KW - PNEUMONIA

U2 - 10.1097/CCM.0000000000000013

DO - 10.1097/CCM.0000000000000013

M3 - Letter

C2 - 24434473

VL - 42

SP - 172

EP - 172

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 2

ER -